This article was originally published in The Silver Sheet
A quote on page 5 of the September 2009 "Silver Sheet" was incorrect. The quote by Jeffrey Secunda, VP for technology and regulatory affairs at device trade association AdvaMed, should have read, "What we would like to see is that the first acknowledgement, which is the most meaningful, will be the actual 'postmark.'" Secunda was speaking about the three-acknowledgement approach to firms used by FDA's electronic Medical Device Reporting (eMDR) program
You may also be interested in...
Pharma manufacturing is operating well below normal levels in India, disrupted by labor absenteeism and supply chain issues amid the ongoing lock-down in the country, though the government is actively engaged in addressing bottlenecks. A speedy recovery is vital not just for domestic supplies.
Moderna is pursuing a single-antigen strategy even though some of its mRNA vaccines have included multiple antigens; the SARS-CoV-2 spike protein likely provides the best antigen for developing immunity against the virus.
Latest warnings also include second and third businesses in US cannabidiol and hemp sector found making unlawful claims for treating and preventing COVID-19. Four of five firms warned apparently responded by removing violative claims from websites and social media posts.